TCMP
MRK icon

Thrive Capital Management (Pennsylvania)’s Merck MRK Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Buy
42,844
+1,825
+4% +$214K 1.04% 19
2026
Q1 		$4.93M Sell
41,019
-3,269
-7% -$377K 1.08% 20
2025
Q4 		$4.66M Sell
44,288
-7,231
-14% -$679K 1.04% 19
2025
Q3 		$4.32M Buy
51,519
+6,117
+13% +$504K 1.12% 22
2025
Q2 		$3.59M Buy
45,402
+26,464
+140% +$2.1M 1.13% 18
2025
Q1 		$1.7M Sell
18,938
-8,252
-30% -$770K 1.02% 28
2024
Q4 		$2.7M Buy
27,190
+8,956
+49% +$923K 1.24% 22
2024
Q3 		$2.07M Buy
18,234
+15,007
+465% +$1.78M 0.98% 23
2024
Q2 		$400K Buy
3,227
+375
+13% +$48.3K 0.18% 140
2024
Q1 		$376K Sell
2,852
-790
-22% -$97.4K 0.2% 70
2023
Q4 		$397K Buy
3,642
+447
+14% +$46.4K 0.21% 78
2023
Q3 		$329K Buy
3,195
+132
+4% +$14.2K 0.18% 91
2023
Q2 		$353K Buy
3,063
+812
+36% +$92.2K 0.2% 86
2023
Q1 		$238K Sell
2,251
-1,907
-46% -$206K 0.15% 111
2022
Q4 		$461K Sell
4,158
-388
-9% -$39.7K 0.3% 65
2022
Q3 		$391K Buy
4,546
+777
+21% +$69.4K 0.26% 66
2022
Q2 		$344K Buy
+3,769
New +$334K 0.24% 70

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s MRK Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Merck (MRK) stake by 4.4% in Q2 2026, buying an estimated $214K and bringing the position to 42,844 shares worth $5.51M. The position accounts for 1.04% of the portfolio, ranked #19.

Thrive Capital Management (Pennsylvania) first reported a position in MRK in Q2 2022 and has held it in 17 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 42,844 shares of Merck worth $5.51M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 1,825 Merck shares in Q2 2026, an estimated $214K.
  • Merck made up 1.04% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #19 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Merck in Q2 2022 and has held it in 17 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.